Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
nxrPGsq5aJWLkzn4
